Assura Plc (LON:AGR – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 39.79 ($0.50) and traded as high as GBX 44.70 ($0.56). Assura shares last traded at GBX 42.96 ($0.54), with a volume of 13,008,762 shares changing hands.
Assura Stock Performance
The business’s fifty day moving average is GBX 38.06 and its two-hundred day moving average is GBX 39.79. The stock has a market capitalization of £1.41 billion, a PE ratio of -41.24, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.05.
Assura Announces Dividend
The firm also recently disclosed a dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, December 12th were paid a GBX 0.84 ($0.01) dividend. The ex-dividend date of this dividend was Thursday, December 12th. This represents a dividend yield of 2.12%. Assura’s payout ratio is currently -286.76%.
About Assura
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.
See Also
- Five stocks we like better than Assura
- The Risks of Owning Bonds
- Finding Hidden Gems: Unconventional Penny Stock Investing
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Price Targets on NVIDIA Rise in Front of Earnings
- What is a Low P/E Ratio and What Does it Tell Investors?
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.